IL-6 LEVELS AND COGNITIVE COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS SECTIONAL STUDY

Hümeyra İvecek; Abdüsselam Şekerci; Betül Sümbül Şekerci

Makale detayları

IL-6 LEVELS AND COGNITIVE COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS SECTIONAL STUDY

Yazarlar:

Hümeyra İvecek | Abdüsselam Şekerci | Betül Sümbül Şekerci

Yayıncı:

Ankara University

Ana Başlıklar:

Klinik Eczacılık ve Eczacılık Uygulaması

Dergi:

Ankara Üniversitesi Eczacılık Fakültesi Dergisi Vol.48 Issue 3, pp.1033-1040

Belge Tipi:

Makale

Yayın Tarihi:

10/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001319086

pISSN:

1015-3918

Anahtar kelimeler:

Özet:

 Objective: It is important to monitor and manage macrovascular and microvascular complications, which are significant causes of mortality and morbidity in type 2 diabetes T2DM. Diabetes-related cognitive impairment is an important complication that has recently attracted more attention, but its pathophysiology and clinical features are not known. The aim of this study was to evaluate the potential role of inflammation in diabetes-related cognitive impairment. Material and Method: A total of 122 participants 67 patients with T2DM and 55 controls took part in this cross-sectional observational clinical study. Cognitive performance was assessed using the Montreal Cognitive Assessment MoCA test. IL-6 levels were measured using the ELISA method on blood samples obtained from the participants. Result and Discussion: Although IL-6 levels increased with diabetes and cognitive impairment, there was no significant difference between the groups p0.05. Except for attention and orientation, we observed significantly more impaired cognitive performance in T2DM patients. The MoCA total score was significantly correlated with age, education level, fasting glucose, HbA1c, and vitamin D levels p0.05. Our results found no evidence that IL-6 is involved in the pathophysiology of cognitive impairment in T2DM, but these findings the importance of cognitive screening in monitoring complications associated with diabetes.

 Objective: It is important to monitor and manage macrovascular and microvascular complications, which are significant causes of mortality and morbidity in type 2 diabetes T2DM. Diabetes-related cognitive impairment is an important complication that has recently attracted more attention, but its pathophysiology and clinical features are not known. The aim of this study was to evaluate the potential role of inflammation in diabetes-related cognitive impairment. Material and Method: A total of 122 participants 67 patients with T2DM and 55 controls took part in this cross-sectional observational clinical study. Cognitive performance was assessed using the Montreal Cognitive Assessment MoCA test. IL-6 levels were measured using the ELISA method on blood samples obtained from the participants. Result and Discussion: Although IL-6 levels increased with diabetes and cognitive impairment, there was no significant difference between the groups p0.05. Except for attention and orientation, we observed significantly more impaired cognitive performance in T2DM patients. The MoCA total score was significantly correlated with age, education level, fasting glucose, HbA1c, and vitamin D levels p0.05. Our results found no evidence that IL-6 is involved in the pathophysiology of cognitive impairment in T2DM, but these findings the importance of cognitive screening in monitoring complications associated with diabetes.

 Objective: It is important to monitor and manage macrovascular and microvascular complications, which are significant causes of mortality and morbidity in type 2 diabetes T2DM. Diabetes-related cognitive impairment is an important complication that has recently attracted more attention, but its pathophysiology and clinical features are not known. The aim of this study was to evaluate the potential role of inflammation in diabetes-related cognitive impairment. Material and Method: A total of 122 participants 67 patients with T2DM and 55 controls took part in this cross-sectional observational clinical study. Cognitive performance was assessed using the Montreal Cognitive Assessment MoCA test. IL-6 levels were measured using the ELISA method on blood samples obtained from the participants. Result and Discussion: Although IL-6 levels increased with diabetes and cognitive impairment, there was no significant difference between the groups p0.05. Except for attention and orientation, we observed significantly more impaired cognitive performance in T2DM patients. The MoCA total score was significantly correlated with age, education level, fasting glucose, HbA1c, and vitamin D levels p0.05. Our results found no evidence that IL-6 is involved in the pathophysiology of cognitive impairment in T2DM, but these findings the importance of cognitive screening in monitoring complications associated with diabetes.

 Amaç: Tip 2 diyabette T2DM önemli mortalite ve morbidite nedenleri olan makrovasküler ve mikrovasküler komplikasyonların izlenmesi ve yönetilmesi önemlidir. Diyabetle ilişkili kognitif bozukluk son dönemler daha fazla dikkat çeken önemli bir komplikasyondur, ancak patofizyolojisi ve klinik özellikleri net olarak bilinmemektedir. Bu çalışmanın amacı diyabetle ilişkili kognitif bozuklukta inflamasyonun potansiyel rolünü değerlendirmektir. Gereç ve Yöntem: Bu kesitsel gözlemsel klinik çalışmaya toplam 122 katılımcı 67 T2DM hastası ve 55 kontrol dahil edilmiştir. Bilişsel performans Montreal Kognitif Değerlendirme MoCA testi kullanılarak değerlendirilmiştir. IL-6 düzeyleri katılımcılardan alınan kan örneklerinde ELISA yöntemi kullanılarak ölçülmüştür. Sonuç ve Tartışma: IL-6 düzeyleri diyabet ve bilişsel bozuklukla birlikte artmasına rağmen, gruplar arasında anlamlı bir fark yoktu p0.05. Dikkat ve oryantasyon dışında, T2DM hastalarında kognitif performansın anlamlı olarak daha fazla bozulduğunu gözlemledik. MoCA toplam skoru yaş, eğitim düzeyi, açlık glukozu, HbA1c ve D vitamini düzeyleri ile anlamlı korelasyon gösterdi p0.05 Sonuçlarımız IL-6nın T2DMde kognitif bozukluğun patofizyolojisinde rol oynadığına dair bir kanıt bulmadı dakat bu bulgular diyabetle ilişkili komplikasyonların izlenmesinde kognitif taramanın önemini vurgulamaktadır.

Makale detayları

IL-6 LEVELS AND COGNITIVE COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS SECTIONAL STUDY

Yazarlar:

Hümeyra İvecek | Abdüsselam Şekerci | Betül Sümbül Şekerci

Yayıncı:

Ankara University

Ana Başlıklar:

Klinik Eczacılık ve Eczacılık Uygulaması

Dergi:

Ankara Üniversitesi Eczacılık Fakültesi Dergisi Vol.48 Issue 3, pp.1033-1040

Belge Tipi:

Makale

Yayın Tarihi:

10/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001319086

pISSN:

1015-3918

Cognitive impairment

inflammation

type 2 diabetesİnflamasyon

kognitif bozulma

tip 2 diyabet

Sayı

Makale detayları

IL-6 LEVELS AND COGNITIVE COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS SECTIONAL STUDY

Yazarlar: Hümeyra İvecek | Abdüsselam Şekerci | Betül Sümbül Şekerci

Yayıncı: Ankara University

Ana Başlıklar: Klinik Eczacılık ve Eczacılık Uygulaması

Dergi: Ankara Üniversitesi Eczacılık Fakültesi Dergisi Vol.48 Issue 3, pp.1033-1040

Belge Tipi: Makale

Yayın Tarihi: 10/2024

Belge Dili: İngilizce

Document ID (Org No.): 2001319086

pISSN: 1015-3918

Cognitive impairment

inflammation

type 2 diabetesİnflamasyon

kognitif bozulma

tip 2 diyabet

Sayı

Yazarlar:

Hümeyra İvecek | Abdüsselam Şekerci | Betül Sümbül Şekerci

Yayıncı:

Ankara University

Ana Başlıklar:

Klinik Eczacılık ve Eczacılık Uygulaması

Dergi:

Ankara Üniversitesi Eczacılık Fakültesi Dergisi Vol.48 Issue 3, pp.1033-1040

Belge Tipi:

Makale

Yayın Tarihi:

10/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001319086

pISSN:

1015-3918